NKTR-0165

N/A

Report date: 2026/03/06 20:02:51
First In Class

Base Information

Drug NameNKTR-0165
Drug Alias NameNKTR-0165
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionTumor necrosis factor receptor superfamily member 1B agonists
TargetsTumor necrosis factor receptor superfamily member 1B
Therapy Area/IndicationsInflammationAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNektar TherapeuticsBiolojic Design Inc
China Registration ClassN/A

Develop Information

Active CompaniesNektar TherapeuticsUc San Francisco
Inactive CompaniesN/A
Active IndicationsInflammationAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A